Clinical Trial: STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Fibrostenotic Crohn's Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 2a, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
Brief Summary:
The goal of this clinical trial is to learn about the safety, pharmacokinetics and pharmacodynamics of AGMB-129 in patients with Crohn's disease.The main questions it aims to answer are:is AGMB-129 safe and well tolerated in these patients?what does the body do to the drug (pharmacokinetics)?what does the drug do to the body (pharmacodynamics)?The participants will be in the study for a total duration of up to 19 weeks, including a 5-week screening period, a 12-week double-blind, placebo-controlled treatment…
Read more